KALOBIOS PHARMACEUTICALS, INC.
Patent Owner
Stats
- 13 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Aug 10, 2017 most recent publication
Details
- 13 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 200 Total Citation Count
- Jan 16, 2001 Earliest Filing
- 22 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0226,227 Treatment of Leukemias and Chronic Myeloproliferative Diseases with Antibodies to EphA3Sep 14, 16Aug 10, 17[A61K, G01N, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9127046 Secretion of antibodies without signal peptides from bacteriaMay 07, 12Sep 08, 15[C12N, C07K]
9109032 Methods of treating hematological proliferative disorders by targeting EphA3 expressed on aberrant vasculature in bone marrowAug 10, 12Aug 18, 15[A61K, G01N, C07K]
9017674 Antibodies to granulocyte-macrophage colony-stimulating factorApr 30, 12Apr 28, 15[A61K, C07K]
8834870 Treatment of leukemias and chronic myeloproliferative diseases with antibodies to EphA3Mar 05, 10Sep 16, 14[A61K]
8211648 Secretion of antibodies without signal peptides from bacteriaNov 14, 05Jul 03, 12[A61K, C07H, C12P, C12N, C40B, C07K]
8168183 Antibodies to granulocyte-macrophage colony-stimulating factorApr 28, 09May 01, 12[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0344,565 ANTIBODIES TO GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORAbandonedApr 02, 15Dec 03, 15[C07K]
2015/0329,647 Methods of Treating Hematological Proliferative Disorders by Targeting EphA3 Expressed on Aberrant Vasculature in Bone MarrowAbandonedJul 30, 15Nov 19, 15[G01N, C07K]
2015/0246,121 METHODS OF TREATING CHRONIC INFLAMMATORY DISEASES USING A GM-CSF ANTAGONISTAbandonedMay 14, 15Sep 03, 15[A61K]
2015/0030,614 ANTIBODIES TO THE PCRV ANTIGEN OF PSEUDOMONAS AERUGINOSAAbandonedOct 08, 14Jan 29, 15[A61K, C07K]
2014/0370,010 TREATMENT OF LEUKEMIAS AND CHRONIC MYELOPROLIFERATIVE DISEASES WITH ANTIBODIES TO EPHA3AbandonedAug 29, 14Dec 18, 14[A61K, C07K]
2013/0156,759 METHODS OF TREATING DEMENTIA USING A GM-CSF ANTAGONISTAbandonedFeb 22, 13Jun 20, 13[A61K]
2013/0109,586 GENERATION OF ANTIBODIES TO AN EPITOPE OF INTEREST THAT CONTAINS A PHOSPHOMIMETIC AMINO ACIDAbandonedOct 04, 12May 02, 13[G01N]
8398972 Methods of treating dementia using a GM-CSF antagonistExpiredFeb 11, 10Mar 19, 13[A61K, A61P, C07K]
2012/0009,191 METHODS OF TREATING BONE-LOSS DISORDERS USING A GM-CSF ANTAGONISTAbandonedJul 08, 11Jan 12, 12[A61K, A61P]
2011/0318,304 DETECTION OF EPHA3 AS A MARKER OF THE PRESENCE OF A SOLID TUMORAbandonedJun 20, 11Dec 29, 11[A61K, C12Q, G01N, A61P]
2011/0243,934 EPHA3 ANTIBODIES FOR THE TREATMENT OF MULTIPLE MYELOMAAbandonedApr 01, 11Oct 06, 11[A61K, C12Q, A61P]
2010/0272,736 COMBINATION ANTIBIOTIC AND ANTIBODY THERAPY FOR THE TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTIONAbandonedFeb 04, 10Oct 28, 10[A61K, A61P]
2009/0181,020 Methods of Treating Bone-Loss Disorders Using a GM-CSF AntagonistAbandonedJan 15, 09Jul 16, 09[A61K, A61P]
2008/0206,241 Methods of Treating Chronic Inflammatory Diseases Using a GM-CSF AntagonistAbandonedNov 21, 07Aug 28, 08[A61K, A61P]
2008/0171,038 METHODS OF TREATING IDIOPATHIC THROMBOCYTOPENIA PURPURA USING A GM-CSF ANTAGONISTAbandonedNov 08, 07Jul 17, 08[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.